SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '4feq'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1A27_A_ESTA350_1 (17-BETA-HYDROXYSTERO ID-DEHYDROGENASE)	4feq	TYROSINE-PROTEIN KINASE RECEPTOR TYRO3 (Mus musculus)	5 / 12	VAL A 576 GLY A 575 LEU A 573 PHE A 555 GLU A 558	None	1.19A	1a27A-4feqA: undetectable	1a27A-4feqA: 23.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1EE2_B_CHDB1250_0 (ALCOHOL DEHYDROGENASE)	4feq	TYROSINE-PROTEIN KINASE RECEPTOR TYRO3 (Mus musculus)	3 / 3	MET A 633 LEU A 636 SER A 637	None	0.62A	1ee2A-4feqA: undetectable	1ee2A-4feqA: 22.56
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1IEP_B_STIB202_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL)	4feq	TYROSINE-PROTEIN KINASE RECEPTOR TYRO3 (Mus musculus)	6 / 12	LEU A 514 VAL A 522 ALA A 538 PHE A 595 GLY A 599 ALA A 662	0T8 A 901 (-3.6A) 0T8 A 901 ( 4.4A) 0T8 A 901 (-3.2A) 0T8 A 901 (-3.9A) 0T8 A 901 ( 3.8A) 0T8 A 901 ( 4.5A)	0.66A	1iepB-4feqA: 22.8	1iepB-4feqA: 39.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1SQN_A_NDRA1001_0 (PROGESTERONE RECEPTOR)	4feq	TYROSINE-PROTEIN KINASE RECEPTOR TYRO3 (Mus musculus)	5 / 12	LEU A 780 LEU A 776 LEU A 754 MET A 716 MET A 748	None	1.49A	1sqnA-4feqA: undetectable	1sqnA-4feqA: 21.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIM_J_CHDJ60_0 (CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART)	4feq	TYROSINE-PROTEIN KINASE RECEPTOR TYRO3 (Mus musculus)	4 / 5	ARG A 624 MET A 657 THR A 658 LEU A 653	None	1.35A	2eimJ-4feqA: undetectable	2eimJ-4feqA: 11.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIM_W_CHDW1060_0 (CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART)	4feq	TYROSINE-PROTEIN KINASE RECEPTOR TYRO3 (Mus musculus)	4 / 5	ARG A 624 MET A 657 THR A 658 LEU A 653	None	1.38A	2eimW-4feqA: undetectable	2eimW-4feqA: 11.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2FUM_A_MIXA539_1 (PROBABLE SERINE/THREONINE-PRO TEIN KINASE PKNB)	4feq	TYROSINE-PROTEIN KINASE RECEPTOR TYRO3 (Mus musculus)	7 / 12	LEU A 514 GLY A 515 VAL A 522 ALA A 538 ASP A 645 ASN A 650 MET A 652	0T8 A 901 (-3.6A) 0T8 A 901 ( 3.9A) 0T8 A 901 ( 4.4A) 0T8 A 901 (-3.2A) None None 0T8 A 901 (-3.9A)	0.97A	2fumA-4feqA: 16.3	2fumA-4feqA: 26.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2ITZ_A_IREA2021_2 (EPIDERMAL GROWTH FACTOR RECEPTOR)	4feq	TYROSINE-PROTEIN KINASE RECEPTOR TYRO3 (Mus musculus)	3 / 3	LEU A 606 LEU A 653 MET A 652	None None 0T8 A 901 (-3.9A)	0.75A	2itzA-4feqA: 25.4	2itzA-4feqA: 34.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2WGJ_A_VGHA2346_1 (HEPATOCYTE GROWTH FACTOR RECEPTOR)	4feq	TYROSINE-PROTEIN KINASE RECEPTOR TYRO3 (Mus musculus)	8 / 12	GLY A 515 VAL A 522 ALA A 538 LEU A 593 MET A 596 GLY A 599 MET A 652 ALA A 662	0T8 A 901 ( 3.9A) 0T8 A 901 ( 4.4A) 0T8 A 901 (-3.2A) 0T8 A 901 (-3.7A) None 0T8 A 901 ( 3.8A) 0T8 A 901 (-3.9A) 0T8 A 901 ( 4.5A)	0.81A	2wgjA-4feqA: 29.6	2wgjA-4feqA: 41.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2WGJ_A_VGHA2346_1 (HEPATOCYTE GROWTH FACTOR RECEPTOR)	4feq	TYROSINE-PROTEIN KINASE RECEPTOR TYRO3 (Mus musculus)	8 / 12	GLY A 515 VAL A 522 ALA A 538 MET A 596 GLY A 599 MET A 652 ALA A 662 ASP A 663	0T8 A 901 ( 3.9A) 0T8 A 901 ( 4.4A) 0T8 A 901 (-3.2A) None 0T8 A 901 ( 3.8A) 0T8 A 901 (-3.9A) 0T8 A 901 ( 4.5A) 0T8 A 901 (-4.5A)	0.92A	2wgjA-4feqA: 29.6	2wgjA-4feqA: 41.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2XP2_A_VGHA9000_1 (TYROSINE-PROTEIN KINASE RECEPTOR)	4feq	TYROSINE-PROTEIN KINASE RECEPTOR TYRO3 (Mus musculus)	7 / 9	LEU A 514 VAL A 522 ALA A 538 LEU A 593 MET A 596 GLY A 599 ASP A 663	0T8 A 901 (-3.6A) 0T8 A 901 ( 4.4A) 0T8 A 901 (-3.2A) 0T8 A 901 (-3.7A) None 0T8 A 901 ( 3.8A) 0T8 A 901 (-4.5A)	0.88A	2xp2A-4feqA: 28.1	2xp2A-4feqA: 36.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3C7Q_A_XINA1172_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	4feq	TYROSINE-PROTEIN KINASE RECEPTOR TYRO3 (Mus musculus)	7 / 12	LEU A 514 GLY A 515 GLU A 524 ALA A 538 LYS A 540 PHE A 595 GLY A 599	0T8 A 901 (-3.6A) 0T8 A 901 ( 3.9A) None 0T8 A 901 (-3.2A) 0T8 A 901 (-3.5A) 0T8 A 901 (-3.9A) 0T8 A 901 ( 3.8A)	0.70A	3c7qA-4feqA: 24.7	3c7qA-4feqA: 37.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3CS9_C_NILC600_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	4feq	TYROSINE-PROTEIN KINASE RECEPTOR TYRO3 (Mus musculus)	5 / 12	ALA A 538 PHE A 595 PHE A 641 HIS A 643 ALA A 662	0T8 A 901 (-3.2A) 0T8 A 901 (-3.9A) None None 0T8 A 901 ( 4.5A)	0.64A	3cs9C-4feqA: 23.6	3cs9C-4feqA: 39.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3CS9_C_NILC600_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	4feq	TYROSINE-PROTEIN KINASE RECEPTOR TYRO3 (Mus musculus)	5 / 12	PHE A 595 PHE A 641 HIS A 643 ALA A 662 ASP A 663	0T8 A 901 (-3.9A) None None 0T8 A 901 ( 4.5A) 0T8 A 901 (-4.5A)	0.81A	3cs9C-4feqA: 23.6	3cs9C-4feqA: 39.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3CS9_D_NILD600_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	4feq	TYROSINE-PROTEIN KINASE RECEPTOR TYRO3 (Mus musculus)	6 / 12	ALA A 538 PHE A 595 GLY A 599 PHE A 641 HIS A 643 ALA A 662	0T8 A 901 (-3.2A) 0T8 A 901 (-3.9A) 0T8 A 901 ( 3.8A) None None 0T8 A 901 ( 4.5A)	0.60A	3cs9D-4feqA: 23.1	3cs9D-4feqA: 39.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3MIY_B_B49B2_1 (TYROSINE-PROTEIN KINASE ITK/TSK)	4feq	TYROSINE-PROTEIN KINASE RECEPTOR TYRO3 (Mus musculus)	5 / 9	ALA A 538 LYS A 540 PHE A 595 MET A 596 GLY A 599	0T8 A 901 (-3.2A) 0T8 A 901 (-3.5A) 0T8 A 901 (-3.9A) None 0T8 A 901 ( 3.8A)	0.72A	3miyB-4feqA: 24.8	3miyB-4feqA: 34.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3MS9_B_STIB1_1 (TYROSINE-PROTEIN KINASE ABL1)	4feq	TYROSINE-PROTEIN KINASE RECEPTOR TYRO3 (Mus musculus)	6 / 12	LEU A 514 VAL A 522 ALA A 538 PHE A 595 GLY A 599 ALA A 662	0T8 A 901 (-3.6A) 0T8 A 901 ( 4.4A) 0T8 A 901 (-3.2A) 0T8 A 901 (-3.9A) 0T8 A 901 ( 3.8A) 0T8 A 901 ( 4.5A)	0.60A	3ms9B-4feqA: 22.7	3ms9B-4feqA: 39.63
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3MSS_B_STIB1_1 (TYROSINE-PROTEIN KINASE ABL1)	4feq	TYROSINE-PROTEIN KINASE RECEPTOR TYRO3 (Mus musculus)	6 / 12	LEU A 514 VAL A 522 ALA A 538 PHE A 595 GLY A 599 ALA A 662	0T8 A 901 (-3.6A) 0T8 A 901 ( 4.4A) 0T8 A 901 (-3.2A) 0T8 A 901 (-3.9A) 0T8 A 901 ( 3.8A) 0T8 A 901 ( 4.5A)	0.67A	3mssB-4feqA: 23.0	3mssB-4feqA: 39.63
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3MSS_D_STID1_1 (TYROSINE-PROTEIN KINASE ABL1)	4feq	TYROSINE-PROTEIN KINASE RECEPTOR TYRO3 (Mus musculus)	6 / 12	LEU A 514 ALA A 538 PHE A 595 GLY A 599 ALA A 662 ASP A 663	0T8 A 901 (-3.6A) 0T8 A 901 (-3.2A) 0T8 A 901 (-3.9A) 0T8 A 901 ( 3.8A) 0T8 A 901 ( 4.5A) 0T8 A 901 (-4.5A)	0.83A	3mssD-4feqA: 23.0	3mssD-4feqA: 39.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3SU9_A_ACTA426_0 (UDP-N-ACETYLGLUCOSAM INE 1-CARBOXYVINYLTRANSF ERASE)	4feq	TYROSINE-PROTEIN KINASE RECEPTOR TYRO3 (Mus musculus)	3 / 3	GLN A 506 GLU A 505 LYS A 505	None	1.12A	3su9A-4feqA: undetectable	3su9A-4feqA: 22.12
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3WZE_A_BAXA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	4feq	TYROSINE-PROTEIN KINASE RECEPTOR TYRO3 (Mus musculus)	8 / 12	LEU A 514 VAL A 522 ALA A 538 LYS A 540 PHE A 595 GLY A 599 LEU A 636 HIS A 643	0T8 A 901 (-3.6A) 0T8 A 901 ( 4.4A) 0T8 A 901 (-3.2A) 0T8 A 901 (-3.5A) 0T8 A 901 (-3.9A) 0T8 A 901 ( 3.8A) None None	0.74A	3wzeA-4feqA: 22.5	3wzeA-4feqA: 37.93
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3ZBF_A_VGHA3000_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ROS)	4feq	TYROSINE-PROTEIN KINASE RECEPTOR TYRO3 (Mus musculus)	6 / 12	LEU A 514 ALA A 538 MET A 596 GLY A 599 ASP A 600 ASP A 663	0T8 A 901 (-3.6A) 0T8 A 901 (-3.2A) None 0T8 A 901 ( 3.8A) 0T8 A 901 (-3.9A) 0T8 A 901 (-4.5A)	0.93A	3zbfA-4feqA: 29.3	3zbfA-4feqA: 39.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4ANQ_A_VGHA9000_1 (ALK TYROSINE KINASE RECEPTOR)	4feq	TYROSINE-PROTEIN KINASE RECEPTOR TYRO3 (Mus musculus)	8 / 9	LEU A 514 VAL A 522 ALA A 538 LEU A 593 MET A 596 GLY A 599 ALA A 662 ASP A 663	0T8 A 901 (-3.6A) 0T8 A 901 ( 4.4A) 0T8 A 901 (-3.2A) 0T8 A 901 (-3.7A) None 0T8 A 901 ( 3.8A) 0T8 A 901 ( 4.5A) 0T8 A 901 (-4.5A)	0.89A	4anqA-4feqA: 16.8	4anqA-4feqA: 35.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4ANS_A_VGHA9000_1 (ALK TYROSINE KINASE RECEPTOR)	4feq	TYROSINE-PROTEIN KINASE RECEPTOR TYRO3 (Mus musculus)	7 / 9	LEU A 514 VAL A 522 ALA A 538 MET A 596 GLY A 599 ALA A 662 ASP A 663	0T8 A 901 (-3.6A) 0T8 A 901 ( 4.4A) 0T8 A 901 (-3.2A) None 0T8 A 901 ( 3.8A) 0T8 A 901 ( 4.5A) 0T8 A 901 (-4.5A)	0.86A	4ansA-4feqA: 22.2	4ansA-4feqA: 35.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4ASD_A_BAXA1500_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	4feq	TYROSINE-PROTEIN KINASE RECEPTOR TYRO3 (Mus musculus)	8 / 12	LEU A 514 VAL A 522 ALA A 538 LYS A 540 PHE A 595 GLY A 599 LEU A 636 HIS A 643	0T8 A 901 (-3.6A) 0T8 A 901 ( 4.4A) 0T8 A 901 (-3.2A) 0T8 A 901 (-3.5A) 0T8 A 901 (-3.9A) 0T8 A 901 ( 3.8A) None None	0.75A	4asdA-4feqA: 22.4	4asdA-4feqA: 34.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4MKC_A_4MKA1503_1 (ALK TYROSINE KINASE RECEPTOR)	4feq	TYROSINE-PROTEIN KINASE RECEPTOR TYRO3 (Mus musculus)	7 / 12	LEU A 514 VAL A 522 ALA A 538 LYS A 540 GLY A 599 ASP A 600 ASP A 663	0T8 A 901 (-3.6A) 0T8 A 901 ( 4.4A) 0T8 A 901 (-3.2A) 0T8 A 901 (-3.5A) 0T8 A 901 ( 3.8A) 0T8 A 901 (-3.9A) 0T8 A 901 (-4.5A)	0.85A	4mkcA-4feqA: 11.0	4mkcA-4feqA: 33.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4MKC_A_4MKA1503_1 (ALK TYROSINE KINASE RECEPTOR)	4feq	TYROSINE-PROTEIN KINASE RECEPTOR TYRO3 (Mus musculus)	7 / 12	LEU A 514 VAL A 522 ALA A 538 LYS A 540 LEU A 593 GLY A 599 ASP A 663	0T8 A 901 (-3.6A) 0T8 A 901 ( 4.4A) 0T8 A 901 (-3.2A) 0T8 A 901 (-3.5A) 0T8 A 901 (-3.7A) 0T8 A 901 ( 3.8A) 0T8 A 901 (-4.5A)	1.01A	4mkcA-4feqA: 11.0	4mkcA-4feqA: 33.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4TWD_J_377J401_1 (CYS-LOOP LIGAND-GATED ION CHANNEL)	4feq	TYROSINE-PROTEIN KINASE RECEPTOR TYRO3 (Mus musculus)	4 / 6	ASN A 640 TYR A 635 LEU A 636 PHE A 565	None	1.14A	4twdI-4feqA: undetectable 4twdJ-4feqA: undetectable	4twdI-4feqA: 23.42 4twdJ-4feqA: 23.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4TWP_A_AXIA601_1 (TYROSINE-PROTEIN KINASE ABL1)	4feq	TYROSINE-PROTEIN KINASE RECEPTOR TYRO3 (Mus musculus)	9 / 12	LEU A 514 VAL A 522 ALA A 538 LYS A 540 PHE A 595 MET A 596 GLY A 599 ALA A 662 ASP A 663	0T8 A 901 (-3.6A) 0T8 A 901 ( 4.4A) 0T8 A 901 (-3.2A) 0T8 A 901 (-3.5A) 0T8 A 901 (-3.9A) None 0T8 A 901 ( 3.8A) 0T8 A 901 ( 4.5A) 0T8 A 901 (-4.5A)	0.97A	4twpA-4feqA: 23.1	4twpA-4feqA: 40.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4TWP_A_AXIA601_1 (TYROSINE-PROTEIN KINASE ABL1)	4feq	TYROSINE-PROTEIN KINASE RECEPTOR TYRO3 (Mus musculus)	8 / 12	LEU A 514 VAL A 522 ALA A 538 PHE A 595 GLY A 599 ASN A 650 ALA A 662 ASP A 663	0T8 A 901 (-3.6A) 0T8 A 901 ( 4.4A) 0T8 A 901 (-3.2A) 0T8 A 901 (-3.9A) 0T8 A 901 ( 3.8A) None 0T8 A 901 ( 4.5A) 0T8 A 901 (-4.5A)	0.77A	4twpA-4feqA: 23.1	4twpA-4feqA: 40.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4TWP_B_AXIB601_1 (TYROSINE-PROTEIN KINASE ABL1)	4feq	TYROSINE-PROTEIN KINASE RECEPTOR TYRO3 (Mus musculus)	8 / 12	LEU A 514 VAL A 522 ALA A 538 LYS A 540 PHE A 595 MET A 596 GLY A 599 ALA A 662	0T8 A 901 (-3.6A) 0T8 A 901 ( 4.4A) 0T8 A 901 (-3.2A) 0T8 A 901 (-3.5A) 0T8 A 901 (-3.9A) None 0T8 A 901 ( 3.8A) 0T8 A 901 ( 4.5A)	0.82A	4twpB-4feqA: 22.9	4twpB-4feqA: 40.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4TWP_B_AXIB601_1 (TYROSINE-PROTEIN KINASE ABL1)	4feq	TYROSINE-PROTEIN KINASE RECEPTOR TYRO3 (Mus musculus)	8 / 12	LEU A 514 VAL A 522 ALA A 538 PHE A 595 GLY A 599 ASN A 650 ALA A 662 ASP A 663	0T8 A 901 (-3.6A) 0T8 A 901 ( 4.4A) 0T8 A 901 (-3.2A) 0T8 A 901 (-3.9A) 0T8 A 901 ( 3.8A) None 0T8 A 901 ( 4.5A) 0T8 A 901 (-4.5A)	0.80A	4twpB-4feqA: 22.9	4twpB-4feqA: 40.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4TWP_B_AXIB601_1 (TYROSINE-PROTEIN KINASE ABL1)	4feq	TYROSINE-PROTEIN KINASE RECEPTOR TYRO3 (Mus musculus)	8 / 12	LEU A 514 VAL A 522 ALA A 538 PHE A 595 MET A 596 GLY A 599 ALA A 662 ASP A 663	0T8 A 901 (-3.6A) 0T8 A 901 ( 4.4A) 0T8 A 901 (-3.2A) 0T8 A 901 (-3.9A) None 0T8 A 901 ( 3.8A) 0T8 A 901 ( 4.5A) 0T8 A 901 (-4.5A)	0.78A	4twpB-4feqA: 22.9	4twpB-4feqA: 40.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4V04_B_0LIB1771_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B)	4feq	TYROSINE-PROTEIN KINASE RECEPTOR TYRO3 (Mus musculus)	5 / 12	MET A 562 LEU A 636 HIS A 643 ALA A 662 ASP A 663	None None None 0T8 A 901 ( 4.5A) 0T8 A 901 (-4.5A)	0.91A	4v04B-4feqA: 25.1	4v04B-4feqA: 39.58
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4XEY_A_1N1A601_1 (TYROSINE-PROTEIN KINASE ABL1)	4feq	TYROSINE-PROTEIN KINASE RECEPTOR TYRO3 (Mus musculus)	7 / 12	LEU A 514 VAL A 522 ALA A 538 LYS A 540 PHE A 595 GLY A 599 ALA A 662	0T8 A 901 (-3.6A) 0T8 A 901 ( 4.4A) 0T8 A 901 (-3.2A) 0T8 A 901 (-3.5A) 0T8 A 901 (-3.9A) 0T8 A 901 ( 3.8A) 0T8 A 901 ( 4.5A)	0.69A	4xeyA-4feqA: 25.0	4xeyA-4feqA: 33.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5AAA_A_VGHA9000_1 (ALK TYROSINE KINASE RECEPTOR)	4feq	TYROSINE-PROTEIN KINASE RECEPTOR TYRO3 (Mus musculus)	7 / 9	LEU A 514 VAL A 522 ALA A 538 LEU A 593 MET A 596 GLY A 599 ASP A 663	0T8 A 901 (-3.6A) 0T8 A 901 ( 4.4A) 0T8 A 901 (-3.2A) 0T8 A 901 (-3.7A) None 0T8 A 901 ( 3.8A) 0T8 A 901 (-4.5A)	0.90A	5aaaA-4feqA: 20.2	5aaaA-4feqA: 37.18
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5AAB_A_VGHA9000_1 (ALK TYROSINE KINASE RECEPTOR)	4feq	TYROSINE-PROTEIN KINASE RECEPTOR TYRO3 (Mus musculus)	7 / 10	LEU A 514 VAL A 522 ALA A 538 LEU A 593 MET A 596 GLY A 599 ASP A 663	0T8 A 901 (-3.6A) 0T8 A 901 ( 4.4A) 0T8 A 901 (-3.2A) 0T8 A 901 (-3.7A) None 0T8 A 901 ( 3.8A) 0T8 A 901 (-4.5A)	0.87A	5aabA-4feqA: 10.7	5aabA-4feqA: 37.18
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5AAB_A_VGHA9000_1 (ALK TYROSINE KINASE RECEPTOR)	4feq	TYROSINE-PROTEIN KINASE RECEPTOR TYRO3 (Mus musculus)	7 / 10	LEU A 514 VAL A 522 ALA A 538 LYS A 540 LEU A 593 MET A 596 GLY A 599	0T8 A 901 (-3.6A) 0T8 A 901 ( 4.4A) 0T8 A 901 (-3.2A) 0T8 A 901 (-3.5A) 0T8 A 901 (-3.7A) None 0T8 A 901 ( 3.8A)	0.67A	5aabA-4feqA: 10.7	5aabA-4feqA: 37.18
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5AAC_A_VGHA9000_1 (ALK TYROSINE KINASE RECEPTOR)	4feq	TYROSINE-PROTEIN KINASE RECEPTOR TYRO3 (Mus musculus)	7 / 10	LEU A 514 VAL A 522 ALA A 538 LEU A 593 MET A 596 GLY A 599 ASP A 663	0T8 A 901 (-3.6A) 0T8 A 901 ( 4.4A) 0T8 A 901 (-3.2A) 0T8 A 901 (-3.7A) None 0T8 A 901 ( 3.8A) 0T8 A 901 (-4.5A)	0.91A	5aacA-4feqA: 10.6	5aacA-4feqA: 36.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5AAC_A_VGHA9000_1 (ALK TYROSINE KINASE RECEPTOR)	4feq	TYROSINE-PROTEIN KINASE RECEPTOR TYRO3 (Mus musculus)	7 / 10	LEU A 514 VAL A 522 ALA A 538 LYS A 540 LEU A 593 MET A 596 GLY A 599	0T8 A 901 (-3.6A) 0T8 A 901 ( 4.4A) 0T8 A 901 (-3.2A) 0T8 A 901 (-3.5A) 0T8 A 901 (-3.7A) None 0T8 A 901 ( 3.8A)	0.67A	5aacA-4feqA: 10.6	5aacA-4feqA: 36.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5AJQ_A_DB8A800_1 (SERINE/THREONINE-PRO TEIN KINASE 10)	4feq	TYROSINE-PROTEIN KINASE RECEPTOR TYRO3 (Mus musculus)	7 / 12	LEU A 514 GLY A 515 ALA A 538 PHE A 595 GLY A 599 ALA A 662 ASP A 663	0T8 A 901 (-3.6A) 0T8 A 901 ( 3.9A) 0T8 A 901 (-3.2A) 0T8 A 901 (-3.9A) 0T8 A 901 ( 3.8A) 0T8 A 901 ( 4.5A) 0T8 A 901 (-4.5A)	0.71A	5ajqA-4feqA: 23.0	5ajqA-4feqA: 27.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5B3S_J_CHDJ101_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	4feq	TYROSINE-PROTEIN KINASE RECEPTOR TYRO3 (Mus musculus)	4 / 7	ARG A 624 MET A 657 THR A 658 LEU A 653	None	0.98A	5b3sA-4feqA: 1.2 5b3sJ-4feqA: undetectable	5b3sA-4feqA: 20.19 5b3sJ-4feqA: 11.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5NKN_A_LOCA201_2 (NEUTROPHIL GELATINASE-ASSOCIATE D LIPOCALIN)	4feq	TYROSINE-PROTEIN KINASE RECEPTOR TYRO3 (Mus musculus)	3 / 3	VAL A 574 LYS A 540 MET A 541	None 0T8 A 901 (-3.5A) None	0.85A	5nknA-4feqA: undetectable	5nknA-4feqA: 12.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5W97_J_CHDJ101_1 (CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	4feq	TYROSINE-PROTEIN KINASE RECEPTOR TYRO3 (Mus musculus)	4 / 5	ARG A 624 MET A 657 THR A 658 LEU A 653	None	1.30A	5w97J-4feqA: undetectable	5w97J-4feqA: 11.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5WAU_J_CHDJ101_1 (CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	4feq	TYROSINE-PROTEIN KINASE RECEPTOR TYRO3 (Mus musculus)	4 / 5	ARG A 624 MET A 657 THR A 658 LEU A 653	None	1.37A	5wauJ-4feqA: undetectable	5wauJ-4feqA: 11.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5XV7_A_EMHA705_1 (SERINE-ARGININE (SR) PROTEIN KINASE 1)	4feq	TYROSINE-PROTEIN KINASE RECEPTOR TYRO3 (Mus musculus)	5 / 12	LEU A 514 GLY A 515 VAL A 522 ALA A 538 ALA A 662	0T8 A 901 (-3.6A) 0T8 A 901 ( 3.9A) 0T8 A 901 ( 4.4A) 0T8 A 901 (-3.2A) 0T8 A 901 ( 4.5A)	0.32A	5xv7A-4feqA: 19.2	5xv7A-4feqA: 12.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5Z86_J_CHDJ101_0 (CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	4feq	TYROSINE-PROTEIN KINASE RECEPTOR TYRO3 (Mus musculus)	4 / 5	ARG A 624 MET A 657 THR A 658 LEU A 653	None	0.99A	5z86J-4feqA: undetectable	5z86J-4feqA: 11.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZCO_J_CHDJ101_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	4feq	TYROSINE-PROTEIN KINASE RECEPTOR TYRO3 (Mus musculus)	4 / 8	ARG A 624 MET A 657 THR A 658 LEU A 653	None	0.97A	5zcoA-4feqA: undetectable 5zcoJ-4feqA: undetectable	5zcoA-4feqA: 20.19 5zcoJ-4feqA: 11.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZCP_J_CHDJ101_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	4feq	TYROSINE-PROTEIN KINASE RECEPTOR TYRO3 (Mus musculus)	4 / 7	ARG A 624 MET A 657 THR A 658 LEU A 653	None	0.96A	5zcpA-4feqA: undetectable 5zcpJ-4feqA: undetectable	5zcpA-4feqA: 20.19 5zcpJ-4feqA: 11.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZCP_J_CHDJ101_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	4feq	TYROSINE-PROTEIN KINASE RECEPTOR TYRO3 (Mus musculus)	5 / 7	ILE A 715 LEU A 605 ARG A 624 THR A 658 LEU A 653	None	1.50A	5zcpA-4feqA: undetectable 5zcpJ-4feqA: undetectable	5zcpA-4feqA: 20.19 5zcpJ-4feqA: 11.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4feq	TYROSINE-PROTEIN KINASE RECEPTOR TYRO3 (Mus musculus)	6 / 12	LEU A 514 VAL A 522 ALA A 538 LYS A 540 GLY A 599 ALA A 662	0T8 A 901 (-3.6A) 0T8 A 901 ( 4.4A) 0T8 A 901 (-3.2A) 0T8 A 901 (-3.5A) 0T8 A 901 ( 3.8A) 0T8 A 901 ( 4.5A)	0.71A	5zv2B-4feqA: 25.4	5zv2B-4feqA: 13.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6HD4_B_STIB602_1 (TYROSINE-PROTEIN KINASE ABL1)	4feq	TYROSINE-PROTEIN KINASE RECEPTOR TYRO3 (Mus musculus)	4 / 6	LEU A 514 PHE A 595 MET A 596 GLY A 599	0T8 A 901 (-3.6A) 0T8 A 901 (-3.9A) None 0T8 A 901 ( 3.8A)	0.62A	6hd4B-4feqA: 22.2	6hd4B-4feqA: 30.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6NKN_W_CHDW102_0 (CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	4feq	TYROSINE-PROTEIN KINASE RECEPTOR TYRO3 (Mus musculus)	4 / 5	ARG A 624 MET A 657 THR A 658 LEU A 653	None	1.27A	6nknW-4feqA: undetectable	6nknW-4feqA: 11.73

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1A27_A_ESTA350_1","17-BETA-HYDROXYSTEROID-DEHYDROGENASE","4feq","TYROSINE-PROTEIN KINASE RECEPTOR TYRO3","Mus musculus",5,"VAL A 576;GLY A 575;LEU A 573;PHE A 555;GLU A 558","None","1.19A","1a27A-4feqA:undetectable","1a27A-4feqA:23.77"],["1EE2_B_CHDB1250_0","ALCOHOL DEHYDROGENASE","4feq","TYROSINE-PROTEIN KINASE RECEPTOR TYRO3","Mus musculus",3,"MET A 633;LEU A 636;SER A 637","None","0.62A","1ee2A-4feqA:undetectable","1ee2A-4feqA:22.56"],["1IEP_B_STIB202_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL","4feq","TYROSINE-PROTEIN KINASE RECEPTOR TYRO3","Mus musculus",6,"LEU A 514;VAL A 522;ALA A 538;PHE A 595;GLY A 599;ALA A 662","0T8 A 901 (-3.6A);0T8 A 901 ( 4.4A);0T8 A 901 (-3.2A);0T8 A 901 (-3.9A);0T8 A 901 ( 3.8A);0T8 A 901 ( 4.5A)","0.66A","1iepB-4feqA:22.8","1iepB-4feqA:39.63"],["1SQN_A_NDRA1001_0","PROGESTERONE RECEPTOR","4feq","TYROSINE-PROTEIN KINASE RECEPTOR TYRO3","Mus musculus",5,"LEU A 780;LEU A 776;LEU A 754;MET A 716;MET A 748","None","1.49A","1sqnA-4feqA:undetectable","1sqnA-4feqA:21.60"],["2EIM_J_CHDJ60_0","CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART","4feq","TYROSINE-PROTEIN KINASE RECEPTOR TYRO3","Mus musculus",4,"ARG A 624;MET A 657;THR A 658;LEU A 653","None","1.35A","2eimJ-4feqA:undetectable","2eimJ-4feqA:11.73"],["2EIM_W_CHDW1060_0","CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART","4feq","TYROSINE-PROTEIN KINASE RECEPTOR TYRO3","Mus musculus",4,"ARG A 624;MET A 657;THR A 658;LEU A 653","None","1.38A","2eimW-4feqA:undetectable","2eimW-4feqA:11.73"],["2FUM_A_MIXA539_1","PROBABLE SERINE\/THREONINE-PROTEIN KINASE PKNB","4feq","TYROSINE-PROTEIN KINASE RECEPTOR TYRO3","Mus musculus",7,"LEU A 514;GLY A 515;VAL A 522;ALA A 538;ASP A 645;ASN A 650;MET A 652","0T8 A 901 (-3.6A);0T8 A 901 ( 3.9A);0T8 A 901 ( 4.4A);0T8 A 901 (-3.2A);None;None;0T8 A 901 (-3.9A)","0.97A","2fumA-4feqA:16.3","2fumA-4feqA:26.74"],["2ITZ_A_IREA2021_2","EPIDERMAL GROWTH FACTOR RECEPTOR","4feq","TYROSINE-PROTEIN KINASE RECEPTOR TYRO3","Mus musculus",3,"LEU A 606;LEU A 653;MET A 652","None;None;0T8 A 901 (-3.9A)","0.75A","2itzA-4feqA:25.4","2itzA-4feqA:34.54"],["2WGJ_A_VGHA2346_1","HEPATOCYTE GROWTH FACTOR RECEPTOR","4feq","TYROSINE-PROTEIN KINASE RECEPTOR TYRO3","Mus musculus",8,"GLY A 515;VAL A 522;ALA A 538;LEU A 593;MET A 596;GLY A 599;MET A 652;ALA A 662","0T8 A 901 ( 3.9A);0T8 A 901 ( 4.4A);0T8 A 901 (-3.2A);0T8 A 901 (-3.7A);None;0T8 A 901 ( 3.8A);0T8 A 901 (-3.9A);0T8 A 901 ( 4.5A)","0.81A","2wgjA-4feqA:29.6","2wgjA-4feqA:41.79"],["2WGJ_A_VGHA2346_1","HEPATOCYTE GROWTH FACTOR RECEPTOR","4feq","TYROSINE-PROTEIN KINASE RECEPTOR TYRO3","Mus musculus",8,"GLY A 515;VAL A 522;ALA A 538;MET A 596;GLY A 599;MET A 652;ALA A 662;ASP A 663","0T8 A 901 ( 3.9A);0T8 A 901 ( 4.4A);0T8 A 901 (-3.2A);None;0T8 A 901 ( 3.8A);0T8 A 901 (-3.9A);0T8 A 901 ( 4.5A);0T8 A 901 (-4.5A)","0.92A","2wgjA-4feqA:29.6","2wgjA-4feqA:41.79"],["2XP2_A_VGHA9000_1","TYROSINE-PROTEIN KINASE RECEPTOR","4feq","TYROSINE-PROTEIN KINASE RECEPTOR TYRO3","Mus musculus",7,"LEU A 514;VAL A 522;ALA A 538;LEU A 593;MET A 596;GLY A 599;ASP A 663","0T8 A 901 (-3.6A);0T8 A 901 ( 4.4A);0T8 A 901 (-3.2A);0T8 A 901 (-3.7A);None;0T8 A 901 ( 3.8A);0T8 A 901 (-4.5A)","0.88A","2xp2A-4feqA:28.1","2xp2A-4feqA:36.89"],["3C7Q_A_XINA1172_1","VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2","4feq","TYROSINE-PROTEIN KINASE RECEPTOR TYRO3","Mus musculus",7,"LEU A 514;GLY A 515;GLU A 524;ALA A 538;LYS A 540;PHE A 595;GLY A 599","0T8 A 901 (-3.6A);0T8 A 901 ( 3.9A);None;0T8 A 901 (-3.2A);0T8 A 901 (-3.5A);0T8 A 901 (-3.9A);0T8 A 901 ( 3.8A)","0.70A","3c7qA-4feqA:24.7","3c7qA-4feqA:37.65"],["3CS9_C_NILC600_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1","4feq","TYROSINE-PROTEIN KINASE RECEPTOR TYRO3","Mus musculus",5,"ALA A 538;PHE A 595;PHE A 641;HIS A 643;ALA A 662","0T8 A 901 (-3.2A);0T8 A 901 (-3.9A);None;None;0T8 A 901 ( 4.5A)","0.64A","3cs9C-4feqA:23.6","3cs9C-4feqA:39.75"],["3CS9_C_NILC600_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1","4feq","TYROSINE-PROTEIN KINASE RECEPTOR TYRO3","Mus musculus",5,"PHE A 595;PHE A 641;HIS A 643;ALA A 662;ASP A 663","0T8 A 901 (-3.9A);None;None;0T8 A 901 ( 4.5A);0T8 A 901 (-4.5A)","0.81A","3cs9C-4feqA:23.6","3cs9C-4feqA:39.75"],["3CS9_D_NILD600_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1","4feq","TYROSINE-PROTEIN KINASE RECEPTOR TYRO3","Mus musculus",6,"ALA A 538;PHE A 595;GLY A 599;PHE A 641;HIS A 643;ALA A 662","0T8 A 901 (-3.2A);0T8 A 901 (-3.9A);0T8 A 901 ( 3.8A);None;None;0T8 A 901 ( 4.5A)","0.60A","3cs9D-4feqA:23.1","3cs9D-4feqA:39.75"],["3MIY_B_B49B2_1","TYROSINE-PROTEIN KINASE ITK\/TSK","4feq","TYROSINE-PROTEIN KINASE RECEPTOR TYRO3","Mus musculus",5,"ALA A 538;LYS A 540;PHE A 595;MET A 596;GLY A 599","0T8 A 901 (-3.2A);0T8 A 901 (-3.5A);0T8 A 901 (-3.9A);None;0T8 A 901 ( 3.8A)","0.72A","3miyB-4feqA:24.8","3miyB-4feqA:34.98"],["3MS9_B_STIB1_1","TYROSINE-PROTEIN KINASE ABL1","4feq","TYROSINE-PROTEIN KINASE RECEPTOR TYRO3","Mus musculus",6,"LEU A 514;VAL A 522;ALA A 538;PHE A 595;GLY A 599;ALA A 662","0T8 A 901 (-3.6A);0T8 A 901 ( 4.4A);0T8 A 901 (-3.2A);0T8 A 901 (-3.9A);0T8 A 901 ( 3.8A);0T8 A 901 ( 4.5A)","0.60A","3ms9B-4feqA:22.7","3ms9B-4feqA:39.63"],["3MSS_B_STIB1_1","TYROSINE-PROTEIN KINASE ABL1","4feq","TYROSINE-PROTEIN KINASE RECEPTOR TYRO3","Mus musculus",6,"LEU A 514;VAL A 522;ALA A 538;PHE A 595;GLY A 599;ALA A 662","0T8 A 901 (-3.6A);0T8 A 901 ( 4.4A);0T8 A 901 (-3.2A);0T8 A 901 (-3.9A);0T8 A 901 ( 3.8A);0T8 A 901 ( 4.5A)","0.67A","3mssB-4feqA:23.0","3mssB-4feqA:39.63"],["3MSS_D_STID1_1","TYROSINE-PROTEIN KINASE ABL1","4feq","TYROSINE-PROTEIN KINASE RECEPTOR TYRO3","Mus musculus",6,"LEU A 514;ALA A 538;PHE A 595;GLY A 599;ALA A 662;ASP A 663","0T8 A 901 (-3.6A);0T8 A 901 (-3.2A);0T8 A 901 (-3.9A);0T8 A 901 ( 3.8A);0T8 A 901 ( 4.5A);0T8 A 901 (-4.5A)","0.83A","3mssD-4feqA:23.0","3mssD-4feqA:39.63"],["3SU9_A_ACTA426_0","UDP-N-ACETYLGLUCOSAMINE 1-CARBOXYVINYLTRANSFERASE","4feq","TYROSINE-PROTEIN KINASE RECEPTOR TYRO3","Mus musculus",3,"GLN A 506;GLU A 505;LYS A 505","None","1.12A","3su9A-4feqA:undetectable","3su9A-4feqA:22.12"],["3WZE_A_BAXA1201_1","VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2","4feq","TYROSINE-PROTEIN KINASE RECEPTOR TYRO3","Mus musculus",8,"LEU A 514;VAL A 522;ALA A 538;LYS A 540;PHE A 595;GLY A 599;LEU A 636;HIS A 643","0T8 A 901 (-3.6A);0T8 A 901 ( 4.4A);0T8 A 901 (-3.2A);0T8 A 901 (-3.5A);0T8 A 901 (-3.9A);0T8 A 901 ( 3.8A);None;None","0.74A","3wzeA-4feqA:22.5","3wzeA-4feqA:37.93"],["3ZBF_A_VGHA3000_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ROS","4feq","TYROSINE-PROTEIN KINASE RECEPTOR TYRO3","Mus musculus",6,"LEU A 514;ALA A 538;MET A 596;GLY A 599;ASP A 600;ASP A 663","0T8 A 901 (-3.6A);0T8 A 901 (-3.2A);None;0T8 A 901 ( 3.8A);0T8 A 901 (-3.9A);0T8 A 901 (-4.5A)","0.93A","3zbfA-4feqA:29.3","3zbfA-4feqA:39.47"],["4ANQ_A_VGHA9000_1","ALK TYROSINE KINASE RECEPTOR","4feq","TYROSINE-PROTEIN KINASE RECEPTOR TYRO3","Mus musculus",8,"LEU A 514;VAL A 522;ALA A 538;LEU A 593;MET A 596;GLY A 599;ALA A 662;ASP A 663","0T8 A 901 (-3.6A);0T8 A 901 ( 4.4A);0T8 A 901 (-3.2A);0T8 A 901 (-3.7A);None;0T8 A 901 ( 3.8A);0T8 A 901 ( 4.5A);0T8 A 901 (-4.5A)","0.89A","4anqA-4feqA:16.8","4anqA-4feqA:35.64"],["4ANS_A_VGHA9000_1","ALK TYROSINE KINASE RECEPTOR","4feq","TYROSINE-PROTEIN KINASE RECEPTOR TYRO3","Mus musculus",7,"LEU A 514;VAL A 522;ALA A 538;MET A 596;GLY A 599;ALA A 662;ASP A 663","0T8 A 901 (-3.6A);0T8 A 901 ( 4.4A);0T8 A 901 (-3.2A);None;0T8 A 901 ( 3.8A);0T8 A 901 ( 4.5A);0T8 A 901 (-4.5A)","0.86A","4ansA-4feqA:22.2","4ansA-4feqA:35.81"],["4ASD_A_BAXA1500_1","VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2","4feq","TYROSINE-PROTEIN KINASE RECEPTOR TYRO3","Mus musculus",8,"LEU A 514;VAL A 522;ALA A 538;LYS A 540;PHE A 595;GLY A 599;LEU A 636;HIS A 643","0T8 A 901 (-3.6A);0T8 A 901 ( 4.4A);0T8 A 901 (-3.2A);0T8 A 901 (-3.5A);0T8 A 901 (-3.9A);0T8 A 901 ( 3.8A);None;None","0.75A","4asdA-4feqA:22.4","4asdA-4feqA:34.99"],["4MKC_A_4MKA1503_1","ALK TYROSINE KINASE RECEPTOR","4feq","TYROSINE-PROTEIN KINASE RECEPTOR TYRO3","Mus musculus",7,"LEU A 514;VAL A 522;ALA A 538;LYS A 540;GLY A 599;ASP A 600;ASP A 663","0T8 A 901 (-3.6A);0T8 A 901 ( 4.4A);0T8 A 901 (-3.2A);0T8 A 901 (-3.5A);0T8 A 901 ( 3.8A);0T8 A 901 (-3.9A);0T8 A 901 (-4.5A)","0.85A","4mkcA-4feqA:11.0","4mkcA-4feqA:33.86"],["4MKC_A_4MKA1503_1","ALK TYROSINE KINASE RECEPTOR","4feq","TYROSINE-PROTEIN KINASE RECEPTOR TYRO3","Mus musculus",7,"LEU A 514;VAL A 522;ALA A 538;LYS A 540;LEU A 593;GLY A 599;ASP A 663","0T8 A 901 (-3.6A);0T8 A 901 ( 4.4A);0T8 A 901 (-3.2A);0T8 A 901 (-3.5A);0T8 A 901 (-3.7A);0T8 A 901 ( 3.8A);0T8 A 901 (-4.5A)","1.01A","4mkcA-4feqA:11.0","4mkcA-4feqA:33.86"],["4TWD_J_377J401_1","CYS-LOOP LIGAND-GATED ION CHANNEL;CYS-LOOP LIGAND-GATED ION CHANNEL","4feq","TYROSINE-PROTEIN KINASE RECEPTOR TYRO3","Mus musculus",4,"ASN A 640;TYR A 635;LEU A 636;PHE A 565","None","1.14A","4twdI-4feqA:undetectable;4twdJ-4feqA:undetectable","4twdI-4feqA:23.42;4twdJ-4feqA:23.42"],["4TWP_A_AXIA601_1","TYROSINE-PROTEIN KINASE ABL1","4feq","TYROSINE-PROTEIN KINASE RECEPTOR TYRO3","Mus musculus",9,"LEU A 514;VAL A 522;ALA A 538;LYS A 540;PHE A 595;MET A 596;GLY A 599;ALA A 662;ASP A 663","0T8 A 901 (-3.6A);0T8 A 901 ( 4.4A);0T8 A 901 (-3.2A);0T8 A 901 (-3.5A);0T8 A 901 (-3.9A);None;0T8 A 901 ( 3.8A);0T8 A 901 ( 4.5A);0T8 A 901 (-4.5A)","0.97A","4twpA-4feqA:23.1","4twpA-4feqA:40.79"],["4TWP_A_AXIA601_1","TYROSINE-PROTEIN KINASE ABL1","4feq","TYROSINE-PROTEIN KINASE RECEPTOR TYRO3","Mus musculus",8,"LEU A 514;VAL A 522;ALA A 538;PHE A 595;GLY A 599;ASN A 650;ALA A 662;ASP A 663","0T8 A 901 (-3.6A);0T8 A 901 ( 4.4A);0T8 A 901 (-3.2A);0T8 A 901 (-3.9A);0T8 A 901 ( 3.8A);None;0T8 A 901 ( 4.5A);0T8 A 901 (-4.5A)","0.77A","4twpA-4feqA:23.1","4twpA-4feqA:40.79"],["4TWP_B_AXIB601_1","TYROSINE-PROTEIN KINASE ABL1","4feq","TYROSINE-PROTEIN KINASE RECEPTOR TYRO3","Mus musculus",8,"LEU A 514;VAL A 522;ALA A 538;LYS A 540;PHE A 595;MET A 596;GLY A 599;ALA A 662","0T8 A 901 (-3.6A);0T8 A 901 ( 4.4A);0T8 A 901 (-3.2A);0T8 A 901 (-3.5A);0T8 A 901 (-3.9A);None;0T8 A 901 ( 3.8A);0T8 A 901 ( 4.5A)","0.82A","4twpB-4feqA:22.9","4twpB-4feqA:40.79"],["4TWP_B_AXIB601_1","TYROSINE-PROTEIN KINASE ABL1","4feq","TYROSINE-PROTEIN KINASE RECEPTOR TYRO3","Mus musculus",8,"LEU A 514;VAL A 522;ALA A 538;PHE A 595;GLY A 599;ASN A 650;ALA A 662;ASP A 663","0T8 A 901 (-3.6A);0T8 A 901 ( 4.4A);0T8 A 901 (-3.2A);0T8 A 901 (-3.9A);0T8 A 901 ( 3.8A);None;0T8 A 901 ( 4.5A);0T8 A 901 (-4.5A)","0.80A","4twpB-4feqA:22.9","4twpB-4feqA:40.79"],["4TWP_B_AXIB601_1","TYROSINE-PROTEIN KINASE ABL1","4feq","TYROSINE-PROTEIN KINASE RECEPTOR TYRO3","Mus musculus",8,"LEU A 514;VAL A 522;ALA A 538;PHE A 595;MET A 596;GLY A 599;ALA A 662;ASP A 663","0T8 A 901 (-3.6A);0T8 A 901 ( 4.4A);0T8 A 901 (-3.2A);0T8 A 901 (-3.9A);None;0T8 A 901 ( 3.8A);0T8 A 901 ( 4.5A);0T8 A 901 (-4.5A)","0.78A","4twpB-4feqA:22.9","4twpB-4feqA:40.79"],["4V04_B_0LIB1771_2","FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B","4feq","TYROSINE-PROTEIN KINASE RECEPTOR TYRO3","Mus musculus",5,"MET A 562;LEU A 636;HIS A 643;ALA A 662;ASP A 663","None;None;None;0T8 A 901 ( 4.5A);0T8 A 901 (-4.5A)","0.91A","4v04B-4feqA:25.1","4v04B-4feqA:39.58"],["4XEY_A_1N1A601_1","TYROSINE-PROTEIN KINASE ABL1","4feq","TYROSINE-PROTEIN KINASE RECEPTOR TYRO3","Mus musculus",7,"LEU A 514;VAL A 522;ALA A 538;LYS A 540;PHE A 595;GLY A 599;ALA A 662","0T8 A 901 (-3.6A);0T8 A 901 ( 4.4A);0T8 A 901 (-3.2A);0T8 A 901 (-3.5A);0T8 A 901 (-3.9A);0T8 A 901 ( 3.8A);0T8 A 901 ( 4.5A)","0.69A","4xeyA-4feqA:25.0","4xeyA-4feqA:33.41"],["5AAA_A_VGHA9000_1","ALK TYROSINE KINASE RECEPTOR","4feq","TYROSINE-PROTEIN KINASE RECEPTOR TYRO3","Mus musculus",7,"LEU A 514;VAL A 522;ALA A 538;LEU A 593;MET A 596;GLY A 599;ASP A 663","0T8 A 901 (-3.6A);0T8 A 901 ( 4.4A);0T8 A 901 (-3.2A);0T8 A 901 (-3.7A);None;0T8 A 901 ( 3.8A);0T8 A 901 (-4.5A)","0.90A","5aaaA-4feqA:20.2","5aaaA-4feqA:37.18"],["5AAB_A_VGHA9000_1","ALK TYROSINE KINASE RECEPTOR","4feq","TYROSINE-PROTEIN KINASE RECEPTOR TYRO3","Mus musculus",7,"LEU A 514;VAL A 522;ALA A 538;LEU A 593;MET A 596;GLY A 599;ASP A 663","0T8 A 901 (-3.6A);0T8 A 901 ( 4.4A);0T8 A 901 (-3.2A);0T8 A 901 (-3.7A);None;0T8 A 901 ( 3.8A);0T8 A 901 (-4.5A)","0.87A","5aabA-4feqA:10.7","5aabA-4feqA:37.18"],["5AAB_A_VGHA9000_1","ALK TYROSINE KINASE RECEPTOR","4feq","TYROSINE-PROTEIN KINASE RECEPTOR TYRO3","Mus musculus",7,"LEU A 514;VAL A 522;ALA A 538;LYS A 540;LEU A 593;MET A 596;GLY A 599","0T8 A 901 (-3.6A);0T8 A 901 ( 4.4A);0T8 A 901 (-3.2A);0T8 A 901 (-3.5A);0T8 A 901 (-3.7A);None;0T8 A 901 ( 3.8A)","0.67A","5aabA-4feqA:10.7","5aabA-4feqA:37.18"],["5AAC_A_VGHA9000_1","ALK TYROSINE KINASE RECEPTOR","4feq","TYROSINE-PROTEIN KINASE RECEPTOR TYRO3","Mus musculus",7,"LEU A 514;VAL A 522;ALA A 538;LEU A 593;MET A 596;GLY A 599;ASP A 663","0T8 A 901 (-3.6A);0T8 A 901 ( 4.4A);0T8 A 901 (-3.2A);0T8 A 901 (-3.7A);None;0T8 A 901 ( 3.8A);0T8 A 901 (-4.5A)","0.91A","5aacA-4feqA:10.6","5aacA-4feqA:36.89"],["5AAC_A_VGHA9000_1","ALK TYROSINE KINASE RECEPTOR","4feq","TYROSINE-PROTEIN KINASE RECEPTOR TYRO3","Mus musculus",7,"LEU A 514;VAL A 522;ALA A 538;LYS A 540;LEU A 593;MET A 596;GLY A 599","0T8 A 901 (-3.6A);0T8 A 901 ( 4.4A);0T8 A 901 (-3.2A);0T8 A 901 (-3.5A);0T8 A 901 (-3.7A);None;0T8 A 901 ( 3.8A)","0.67A","5aacA-4feqA:10.6","5aacA-4feqA:36.89"],["5AJQ_A_DB8A800_1","SERINE\/THREONINE-PROTEIN KINASE 10","4feq","TYROSINE-PROTEIN KINASE RECEPTOR TYRO3","Mus musculus",7,"LEU A 514;GLY A 515;ALA A 538;PHE A 595;GLY A 599;ALA A 662;ASP A 663","0T8 A 901 (-3.6A);0T8 A 901 ( 3.9A);0T8 A 901 (-3.2A);0T8 A 901 (-3.9A);0T8 A 901 ( 3.8A);0T8 A 901 ( 4.5A);0T8 A 901 (-4.5A)","0.71A","5ajqA-4feqA:23.0","5ajqA-4feqA:27.05"],["5B3S_J_CHDJ101_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","4feq","TYROSINE-PROTEIN KINASE RECEPTOR TYRO3","Mus musculus",4,"ARG A 624;MET A 657;THR A 658;LEU A 653","None","0.98A","5b3sA-4feqA:1.2;5b3sJ-4feqA:undetectable","5b3sA-4feqA:20.19;5b3sJ-4feqA:11.73"],["5NKN_A_LOCA201_2","NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN","4feq","TYROSINE-PROTEIN KINASE RECEPTOR TYRO3","Mus musculus",3,"VAL A 574;LYS A 540;MET A 541","None;0T8 A 901 (-3.5A);None","0.85A","5nknA-4feqA:undetectable","5nknA-4feqA:12.50"],["5W97_J_CHDJ101_1","CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","4feq","TYROSINE-PROTEIN KINASE RECEPTOR TYRO3","Mus musculus",4,"ARG A 624;MET A 657;THR A 658;LEU A 653","None","1.30A","5w97J-4feqA:undetectable","5w97J-4feqA:11.73"],["5WAU_J_CHDJ101_1","CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","4feq","TYROSINE-PROTEIN KINASE RECEPTOR TYRO3","Mus musculus",4,"ARG A 624;MET A 657;THR A 658;LEU A 653","None","1.37A","5wauJ-4feqA:undetectable","5wauJ-4feqA:11.73"],["5XV7_A_EMHA705_1","SERINE-ARGININE (SR) PROTEIN KINASE 1","4feq","TYROSINE-PROTEIN KINASE RECEPTOR TYRO3","Mus musculus",5,"LEU A 514;GLY A 515;VAL A 522;ALA A 538;ALA A 662","0T8 A 901 (-3.6A);0T8 A 901 ( 3.9A);0T8 A 901 ( 4.4A);0T8 A 901 (-3.2A);0T8 A 901 ( 4.5A)","0.32A","5xv7A-4feqA:19.2","5xv7A-4feqA:12.85"],["5Z86_J_CHDJ101_0","CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","4feq","TYROSINE-PROTEIN KINASE RECEPTOR TYRO3","Mus musculus",4,"ARG A 624;MET A 657;THR A 658;LEU A 653","None","0.99A","5z86J-4feqA:undetectable","5z86J-4feqA:11.73"],["5ZCO_J_CHDJ101_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","4feq","TYROSINE-PROTEIN KINASE RECEPTOR TYRO3","Mus musculus",4,"ARG A 624;MET A 657;THR A 658;LEU A 653","None","0.97A","5zcoA-4feqA:undetectable;5zcoJ-4feqA:undetectable","5zcoA-4feqA:20.19;5zcoJ-4feqA:11.73"],["5ZCP_J_CHDJ101_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","4feq","TYROSINE-PROTEIN KINASE RECEPTOR TYRO3","Mus musculus",4,"ARG A 624;MET A 657;THR A 658;LEU A 653","None","0.96A","5zcpA-4feqA:undetectable;5zcpJ-4feqA:undetectable","5zcpA-4feqA:20.19;5zcpJ-4feqA:11.73"],["5ZCP_J_CHDJ101_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","4feq","TYROSINE-PROTEIN KINASE RECEPTOR TYRO3","Mus musculus",5,"ILE A 715;LEU A 605;ARG A 624;THR A 658;LEU A 653","None","1.50A","5zcpA-4feqA:undetectable;5zcpJ-4feqA:undetectable","5zcpA-4feqA:20.19;5zcpJ-4feqA:11.73"],["5ZV2_B_LEVB801_1","FIBROBLAST GROWTH FACTOR RECEPTOR 1","4feq","TYROSINE-PROTEIN KINASE RECEPTOR TYRO3","Mus musculus",6,"LEU A 514;VAL A 522;ALA A 538;LYS A 540;GLY A 599;ALA A 662","0T8 A 901 (-3.6A);0T8 A 901 ( 4.4A);0T8 A 901 (-3.2A);0T8 A 901 (-3.5A);0T8 A 901 ( 3.8A);0T8 A 901 ( 4.5A)","0.71A","5zv2B-4feqA:25.4","5zv2B-4feqA:13.25"],["6HD4_B_STIB602_1","TYROSINE-PROTEIN KINASE ABL1","4feq","TYROSINE-PROTEIN KINASE RECEPTOR TYRO3","Mus musculus",4,"LEU A 514;PHE A 595;MET A 596;GLY A 599","0T8 A 901 (-3.6A);0T8 A 901 (-3.9A);None;0T8 A 901 ( 3.8A)","0.62A","6hd4B-4feqA:22.2","6hd4B-4feqA:30.89"],["6NKN_W_CHDW102_0","CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","4feq","TYROSINE-PROTEIN KINASE RECEPTOR TYRO3","Mus musculus",4,"ARG A 624;MET A 657;THR A 658;LEU A 653","None","1.27A","6nknW-4feqA:undetectable","6nknW-4feqA:11.73"]]